Clinical Trials Logo

Insulin Resistance clinical trials

View clinical trials related to Insulin Resistance.

Filter by:

NCT ID: NCT01877551 Completed - Clinical trials for Endoplasmic Reticulum Stress

Tauroursodeoxycholic Acid for Protease-inhibitor Associated Insulin Resistance

Start date: September 2013
Phase: N/A
Study type: Interventional

Rates of cardiovascular disease and diabetes are more than 2-fold greater in HIV infected people than the general population. Protease inhibitor booster antiretroviral therapy (PI-ART) which is used by ~50% of HIV infected people in the USA is an established risk factor for diabetes. Tauroursodeoxycholic acid (TUDCA), a naturally occurring bile salt, improves insulin sensitivity in HIV uninfected subjects, although the mechanisms for these benefits are unclear. This study will explore the hypothesis that TUDCA will improve insulin action in people with HIV who are receiving PI-ART. Further, this project will clarify the molecular mechanisms responsible for these improvements potentially benefiting society, irrespective of HIV status.

NCT ID: NCT01876108 Completed - Insulin Resistance Clinical Trials

The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease

Start date: July 2012
Phase: Phase 2
Study type: Interventional

The role of Helicobacter pylori(HP)in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) is controversial.

NCT ID: NCT01872533 Completed - Insulin Resistance Clinical Trials

Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)

SLEEP HIGH
Start date: July 2011
Phase: Phase 0
Study type: Interventional

The purpose of this study is to look at how a reduction in oxygen levels (hypoxia) influences insulin sensitivity and carbohydrate metabolism. It is expected that 10 nights of exposure to moderate hypoxia (~ 15% O2, similar to conditions at an altitude of ~7500 feet) will improve glucose metabolism.

NCT ID: NCT01862757 Completed - Obesity Clinical Trials

Pilot Study of Strength Testing in Overweight Women With or Without Insulin Resistance

Start date: May 6, 2013
Phase: N/A
Study type: Observational

Background: - Some people who are obese may have decreased muscle strength. They may have greater muscle mass shown in scans, but they show poor results in exercise tests. Poor muscle strength might cause some of the difficulty with exercise performance. Researchers want to test muscle strength in the arms and legs of overweight women. They will also see how insulin resistance affects muscle strength in these women. Objectives: - To test muscle strength in overweight women. - To see if insulin resistance affects muscle strength. Eligibility: - Women at least 18 years of age who are overweight (body mass index greater than 25 kg/m2). Design: - Participants will be asked to fast before having an initial blood test to measure glucose and insulin levels. - On a different day, they will have the strength testing. The first test will measure leg muscle strength by testing the quadriceps and the hamstrings. The second test will measure arm muscle strength by testing the biceps and triceps. The final test will measure hand muscle (grip) strength. - All the tests should take about an hour.

NCT ID: NCT01860911 Completed - Obesity Clinical Trials

Plasma Triglyceride Extraction by The Muscle

Start date: April 2013
Phase: Phase 1
Study type: Interventional

Increased accumulation of fat into the muscles is associated with what is called insulin-resistant state, which is a pre-diabetic state. The purpose of this research is to find out how fat circulating in the blood following fat consumption is taken up by the muscles in healthy people as well as people that are insulin-resistant. The investigators are specifically interested in how a hormone called insulin is involved in this process. Findings from this research will contribute to our understanding of why insulin-resistant people have increased accumulation of fat in their muscles, and ultimately help to design appropriate interventions to prevent type 2 Diabetes.

NCT ID: NCT01857167 Completed - Type 2 Diabetes Clinical Trials

Effect of Omega-3 Fatty Acids on Insulin Sensitivity in Chinese Type 2 Diabetic Patients

Start date: June 2013
Phase: N/A
Study type: Interventional

This study is to examine the change of fasting insulin, glucose, insulin sensitivity and related traits in response to the six month treatment of omega-3 fatty acids, including fish oil and flaxseed oil, in Chinese type 2 diabetic patients. Corn oil, rich in omega-6 fatty acids, will be selected as a controlled oil. The investigators hypothesize that omega-3 fatty acids could improve insulin sensitivity and glucose metabolism in Chinese type 2 diabetic patients.

NCT ID: NCT01856946 Completed - Insulin Resistance Clinical Trials

Effect of Vitamin D Supplementation on Oral Glucose Tolerance Among Obese Adolescents

Start date: May 2013
Phase: N/A
Study type: Interventional

Childhood obesity is a rapidly growing epidemic in the US and the world. Current estimates suggest that 30% of our nation's children are either overweight ot obese. Obesity is a major risk factor towards the development of insulin resistance, which, in turn is a major risk factor for the development of type 2 diabetes. Prior research has suggested that vitamin D therapy may be a safe, inexpensive, and effective method of reducing insulin resistance and a person's risk of developing diabetes. The investigators' prior studies have shown that daily 4,000 IU vitamin D therapy is a safe and effective method of improving insulin resistance based on a calculation called the HOMA-IR. The next step in identifying whether vitamin D truly improves insulin resistance is to use oral glucose tolerance testing (OGTT), which is a better real-life measure of insulin resistance compared to the previously used HOMA-IR.

NCT ID: NCT01848353 Completed - Obesity Clinical Trials

Financial Incentives to Exercise for Adolescents

MOVE
Start date: May 2013
Phase: N/A
Study type: Interventional

Among youth populations, American Indians have the highest prevalence of diabetes in the United States. This study will use exercise as the principal lifestyle modification approach to reduce the risk of diabetes in this population. The Choctaw Nation of Oklahoma has several excellent, but underutilized wellness facilities in their Health Services Area in rural Southeast Oklahoma, a low socioeconomic region. It has been established that exercise lowers diabetes risk, and many overweight/obese, insulin resistant American Indian youth who live in this region would benefit from an increase in regular exercise. The challenge is to modify behavior so that routine exercise is established and maintained. The proposed study will test whether monetary incentives can elicit greater frequency and duration of exercise in American Indian youth when transportation and access barriers are reduced.

NCT ID: NCT01847456 Completed - Insulin Sensitivity Clinical Trials

Influence of Brain Insulin Sensitivity on Peripheral Insulin Sensitivity

Start date: April 2013
Phase: N/A
Study type: Interventional

The researchers will investigate if brain insulin action influences peripheral insulin sensitivity in healthy humans.

NCT ID: NCT01845896 Completed - Multiple Sclerosis Clinical Trials

Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple Sclerosis

Start date: March 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of a combined training programme and a high intensity interval training programme on insulin resistance, muscle strength/ muscle contractile properties, aerobic capacity and body composition in MS patients. It is assumed that the the above mentioned clinical parameters will improve due to physical exercise.